Article
Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.
Bone marrow transplantation - 1 Mar 1994
Neubauer M A, Benyunes M C, Thompson J A, Bensinger W I, Lindgren C G, Buckner C D, Fefer A
Abstract excerpt
Immunotherapy with interleukin-2 (IL-2) early after peripheral blood stem cell transplantation (PBSCT) is being considered as a potential way to eradicate minimal residual disease. The aim of this study was to determine whether lymphocytes which can acquire lymphokine-activated killer (LAK) cell activity are present in PBSC and in the blood of patients after PBSCT. Fresh and cryopreserved G-CSF-mobilized PBSC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.